The impact of mental illness on sexual dysfunction

Advances in Psychosomatic Medicine

Volumn 29, Issue , 2008, Pages 89-106

  Zemishlany, Z ^a   Weizman, A ^b  

^a GEHA MENTAL HEALTH CENTER   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

ANXIETY; BORDERLINE STATE; COMORBIDITY; DEPRESSION; DRUG EFFECT; EATING DISORDER; FEMALE; HOSPITALIZATION; HUMAN; LIBIDO; MALE; MENTAL DISEASE; MENTAL HEALTH; PERSONALITY DISORDER; PSYCHOSEXUAL DISORDER; REVIEW; SEXUAL DYSFUNCTION;

ANTIDEPRESSIVE AGENTS; ANXIETY; BORDERLINE PERSONALITY DISORDER; COMORBIDITY; DEPRESSION; EATING DISORDERS; FEMALE; HUMANS; LIBIDO; MALE; MENTAL DISORDERS; MENTAL HEALTH; PERSONALITY DISORDERS; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

EID: 46449083032     PISSN: 00653268     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000126626     Document Type: Review

References (83)

1. Laumann EO, Paik A, Rosen RC: Sexual dysfunction in the United States prevalence and predictors. JAMA 1999;281:537-544.
2. Peuskens J, Sienaert P, De Hert M: Sexual dysfunction: the unspoken side effect of antipsychotics. Eur Psychiatry 1998;13:23s-30s.
3. Rosen RC, Lane RM, Menza M: Effects of SSRI's on sexual function: a critical review. J Clin Psychopharmacol 1999;19:67-85.
4. Clayton AH, Pradko JF, Croft HA, Montano CB, Leadbetter RA, Bolden-Watson C, Bass KI, Donahue RMJ, Jamerson BD, Metz A: Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry 2002;63:357-366.
5. Osvath P, Fekete S, Voros V, Vitrai J: Sexual dysfunction among patients treated with antidepressants - a Hungarian retrospective study. Eur Psychiatry 2003;18:412-414.
6. Kaplan HS: Anxiety and sexual dysfunction. J Clin Psychiatry 1988;49:21-25.
7. Letourneau EJ, Schewe PA, Frueh BC: Preliminary evaluation of sexual problems in combat veterans with PTSD. J Trauma Stress 1997;10:125-132.
8. Pfaus JG, Everitt BJ: The psychopharmacology of sexual behavior; in Bloom FE, Kupfer DJ (eds): Psychopharmacology: The Fourth Generation of Progress. New York, Raven Press, 1995, pp 743-758.
9. Meston CM, Frohlich PF: The neurobiology of sexual function. Arch Gen Psychiatry 2000;57:1012-1030.
10. Finkel MS, Laghrissi-Thode F, Pollock BG, Rong J: Paroxetine is a novel nitric oxide sythase inhibitor. Psychopharmacol Bull 1996;32:653-658.
11. Kotin J, Wibert DE, Verburg D, Soldinger SM: Thioridazine and sexual dysfunction. Am J Psychiatry 1976;133:82-85.
12. Ghadirian AM, Chouinard G, Annable L: Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients. J Nerv Ment Dis 1982;170:463-467.
13. Smith SM, O'Keane V, Murray R: Sexual dysfunction in patients taking conventional antipsychotic medication. Br J Psychiatry 2002;181:49-55.
14. Aizenberg D, Zemishlany Z, Dorfman-Etrog P, Weizman A: Sexual dysfunction in male schizophrenic patients. J Clin Psychiatry 1995;56:137-141.
15. Macdonald S, Halliday J, MacEwan T, Sharkey V, Farrington S, Wall S, McCreadie RG: Nithsdale schizophrenia surveys 24: sexual dysfunction. Br J Psychiatry 2003;182:50-56.
16. Angrist B, Gershon S: Clinical response to several dopamine agonists of schizophrenic and non-schizophrenic subjects. Adv Biochem Psychopharmacol 1977;16:677-680.
17. Schiavi RC, Segraves RT: The biology of sexual function. Psychiatr Clin North Am 1995;18:7-23.
18. Valevski A, Modai I, Zbarski E, Zemishlany Z, Weizman A: Effect of amantadine on sexual dysfunction in neuroleptic-treated male schizophrenic patients. Clin Neuropharmacol 1998;21:355-357.
19. Berry MD, Juorio AV, Pasteron IA: Possible mechanisms of action of deprenyl and other MAO-B inhibitors in some neurologic and psychiatric disorders. Prog Neurobiol 1994;44:141-161.
20. Kodesh A, Weizman A, Aizenberg D, Hermesh H, Gelkopf M, Zemishlany Z: Selegiline in the treatment of sexual dysfunction in schizophrenia patients maintained on neuroleptics: a pilot study. Clin Neuropharmacol 2003;26:193-195.
21. Cutler AJ: Sexual dysfunction and antipsychotic treatment. Psychoneuroendocrinology 2003;28:69-82.
22. Hummer M, Kemmler G, Kurz M, Kurzthaler I, Oberbauer H, Fleischhacker W: Sexual disturbances during clozapine and haloperidol treatment for schizophrenia. Am J Psychiatry 1999;156:631-633.
23. Aizenberg D, Modai I, Landa A, Gil-Ad I, Weizman A: Comparison of sexual dysfunction in male schizophrenic patients maintained on treatment with classical antipsychotics versus clozapine. J Clin Psychiatry 2001;62:541-544.
24. Kleinberg DK, Davis JM, de Coster R, Van Baelen B, Brecher M: Prolactin levels and adverse events in patients treated with resperidone. J Clin Psychopharmacol 1999;19:57-61.
25. Peuskens J: Risperidone in the treatment of patients with chronic schizophrenia: a multinational, multicentre, double-blind, parallel group study versus haloperidol. Br J Psychiatry 1995;166:712-726.
26. Bitter I, Basson BR, Dossenbach MR: Antipsychotic treatment and sexual functioning in first-time neuroleptic-treated schizophrenic patients. Int Chil Psychopharmacol 2005;20:19-21.
27. Tran PV, Hamilton SH, Kuntz AJ, Potvin JH, Andersen SW, Beasley C, Tollefson GD: Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders. J Clin Psychopharmacol 1997;17:407-418.
28. Dossenbach M, Dyachkova Y, Pirildar S, Anders M, Khalil A, Araszkiewicz A, Shakhnovich T, Akram A, Pecenak J, McBride M, Treuer T: Effects of atypical and typical antipsychotic treatments on sexual function in patients with schizophrenia: 12-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study. Eur Psychiatry 2006;21:251-258.
29. Hamner M: The effect of atypical antipsychotics on serum prolactin levels. Ann Clin Psychiatry 2002; 14:163-173.
30. Kelly DL, Conley RR: A randomized double-blind 12 week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia. Psychoneuroendocrinology 2006;31:340-346.
31. Benatov R, Reznik I, Zemishlany Z: Sildenafil citrate (Viagra) treatment of sexual dysfunction in a schizophrenic patient. Eur Psychiatry 1999;14:353-355.
32. Aviv A, Shelef A, Weizman A: An open-label trial of sildenafil addition in risperidone-treated male schizophrenia patients with erectile dysfunction. J Clin Psychiatry 2004;65:97-103.
33. Gopalakrishnan R, Jacob KS, Kuruvilla A, Vasantharaj B, John JK: Sildenafil in the treatment of antipsychotic-induced erectile dysfunction: a randomized, double-blind, placebo-controlled, flexibledose, two-way crossover trial. Am J Psychiatry 2006;163:494-499.
34. Casper RC, Redmond DE, Katz MM, Schaffer CB, Davis JM, Doslow SH: Somatic symptoms in primary affective disorder. Arch Gen Psychiatry 1985;42:1098-1104.
35. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB: Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994;151:54-61.
36. Thase ME, Reynolds CF III, Jennings JR, Frank E, Howell JR, Houck PR, Berman S, Kupfer D: Nocturnal penile tumexcence is diminished in depressed men. Biol Psychiatry 1988;24:33-46.
37. Thase ME, Reynolds CF III, Jennings JR, Frank E, Garamoni GL, Nofzinger EA, Fascizka AL, Kupfer DJ: Diminished nocturnal penile tumescence in depression: a repliaction study. Biol Psychiatry 1992;31:1136-1142.
38. Harrison WM, Rabkin JG, Ehrhardt AA, Stewart JW, McGrath PJ, Ross D, Quitkin FM: Effects of antidepressant medication on sexual function: a controlled study. J Clin Psychopharmacol 1986;6:144-149.
39. Monteiro WO, Noshirvani HF, Marks IM, Lelliott PT: Anorgasmia from clomipramine in obsessive-compulsive disorder: a controlled trial. Br J Psychiatry 1987;151:107-112.
40. Physicians' desk reference, ed 45. Oradell NJ, Medical Economics Data, 1991, p 904.
41. Patterson WM: Fluoxetine-induced sexual dysfunction. J Clin Psychiatry 1993;54:71.
42. Balon R, Yeragani VK, Pohl R, Ramesh C: Sexual dysfunction during antidepressant treatment. J Clin Psychiatry 1993;54:209-212.
43. Montejo-González AL, Llorca G, Izquierdo JA, Ledesma A, Bousoño M, Calcedo A, Carrasco JL, Ciudad J, Daniel E, De la Gandara J, Derecho J, Franco M, Gomez MJ, Macias JA, Martin T, Perez V, Sanchez JM, Sanchez S, Vicens E: SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther 1997;23:176-194.
44. Williams VS, Baldwin DS, Hogue SL, Fehnel SE, Hollis KA, Edin HM: Estimating the prevalence and impact of antidepressant-induced sexual dysfunction in 2 European countries: a cross-sectional patient survey. J Clin Psychiatry 2006;67:204-210.
45. Clayton AH, McGarvey EL, Clavet GJ: The Changes in Sexual Functioning Questionnaire (CSFQ): development, reliability, and validity. Psychopharmacol Bull 1997;33:731-745.
46. Waldinger MD, Hengeveld MW, Zwinderman AH, Olivier B: Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. J Clin Psychopharmacol 1998;18:274-281.
47. Landén M, Högberg P, Thase ME: Incidence of sexual side effects in refractory depression during treatment with citalopram or paroxetine. J Clin Psychiatry 2005;66:100-106.
48. Walker PW, Cole JO, Gardner EA, Hughes AR, Johnston JA, Batey SR, Lineberry CG: Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion. J Clin Psychiatry 1993;54:459-465.
49. Delgado PL, Brannan SK, Mallinckrodt CH, Tran PV, McNamara RK, Wang F, Watkin JG, Detke MJ: Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder. J Clin Psychiatry 2005;66:686-692.
50. Rothschild AJ: Selective serotonin reuptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday. Am J Psychiatry 1995;152:1514-1516.
51. Aizenberg D, Zemishlany Z, Weizman A: Cyproheptadine treatment of sexual dysfunction induced by serotonin reuptake inhibitors. Clin Neuropharmacol 1995;18:320-324.
52. Aizenberg D, Gur S, Zemishlany Z, Granek M, Jeczmien P, Weizman A: Mianserin, a 5-HT2a/2c and alpha 2 antagonist, in the treatment of sexual dysfunction induced by serotonin reuptake inhibitors. Clin Neuropharmacol 1997;20:210-214.
53. Aizenberg D, Naor S, Zemishlany Z, Weizman A: The serotonin antagonist mianserin for treatment of serotonin reuptake inhibitor-induced sexual dysfunction in women: an open-label add-on study. Clin Neuropharmacol 1999;22:347-350.
54. Feiger A, Kiev A, Shrivastava RK, Wisselink PG, Wilcox CS: Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction. J Clin Psychiatry 1996;57:53-62.
55. Norden MJ: Buspirone treatement of sexual dysfunction associated with selective serotonin reuptake inhibitors. Depression 1994;2:109-112.
56. Landén M, Eriksson E, Agren H, Fahlén T: Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors. J Clin Psychopharmacol 1999;19:268-271.
57. Michelson D, Bancroft J, Targum S, Kim Y, Tepner R: Female sexual dysfunction associated with antidepressant administration: a randomized, placebocontrolled study of pharmacologic intervention. Am J Psychiatry 2000;157:239-243.
58. Masand PS, Ashton AK, Gupta S, Frank B: Sustained-release bupropion for selective serotonin reuptake inhibitor-induced sexual dysfunction: a randomized, double-blind, placebo-controlled, parallel-group study. Am J Psychiatry 2001;158:805-807.
59. Clayton AH, Warnock JK, Kornstein SG, Pinkerton R, Sheldon-Keller A, McGarvey EL: A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry 2004;65:62-67.
60. Koutouvidis N, Pratikakis M, Fotiadou A: The use of mirtazapine in a group of 11 patients following poor compliance to selective serotonin reuptake inhibitor treatment due to sexual dysfunction. Int Clin Psychopharmacol 1999;14:253-255.
61. Clayton AH, Zajecka J, Ferguson JM, Filipiak-Reisner JK, Brown MT, Schwartz GE: Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder. Int Clin Psychopharmacol 2003;18:151-156.
62. Nurnberg HG, Gelenberg A, Hargreave TB, Harrison WM, Siegel RL, Smith MD: Efficacy of sildenafil citrate for the treatment of erectile dysfunction in men taking serotonin reuptake inhibitors. Am J Psychiatry 2001;158:1926-1928.
63. Fava M, Nurnberg HG, Seidman SN, Holloway W, Nicholas S, Tseng LJ, Stecher VJ: Efficacy and safety of sildenafil in men with serotonergic antidepressant-associated erectile dysfunction: results from a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2006;67:240-246.
64. Aizenberg D, Weizman A, Barak Y: Sildenafil for selective serotonin reuptake inhibitor-induced erectile dysfunction in elderly male depressed patients. J Sex Marital Ther 2003;29:297-303.
65. Hedon F: Anxiety and erectile dysfunction: a global approach to ED enhances results and quality of life. Int J Impot Res 2003;15:S16-S19.
66. Janssen PL: Psychodynamic study of male potency disorders. An overview. Psychother Psychosom 1985;44:6-17.
67. Heimberg RG, Barlow DH: Psychosocial treatments for social phobia. Psychosomatics 1988;29:27-37.
68. Leary MR, Dobbins SE: Social anxiety, sexual behavior, and contraceptive use. J Pers Soc Psychol 1983;45:1347-1354.
69. Figueira I, Possidente E, Marques C, Hayes K: Sexual dysfunction: a neglected complication of panic disorder and social phobia. Arch Sex Behav 2001;30:369-377.
70. Bodinger L, Hermesh H, Aizenberg D, Valevski A, Marom S, Shiloh R, Gothelf D, Zemishlany Z, Weizman A: Sexual function and behavior in social phobia. J Clin Psychiatry 2002;63:874-879.
71. Schiavi RC, Schreiner-Engel P, Mandeli J, Schanzer H, Cohen E: Healthy aging and male sexual function. Am J Psychiatry 1990;147:766-771.
72. Kaplan HS: Anxiety and sexual dysfunction. J Clin Psychiatry 1988;49:21-25.
73. Fossey MD, Hamner MB: Clonazepam-related sexual dysfunction in male veterans with PTSD. Anxiety 1994-1995;1:233-236.
74. Kotler M, Cohen H, Aizenberg D, Matar M, Loewenthal U, Kaplan Z, Miodownik H, Zemishlany Z: Sexual dysfunction in male posttraumatic stress disorder patients. Psychother Psychosom 2000;69:309-315.
75. Horowitz M, Wilner N, Alvarez W: Impact of Event Scale: a measure of subjective stress. Psychosom Med 1979;41:209-218.
76. Derogatis L, Cleary P: A confirmation of dimensional structure of the SCL-90: A study in construct validity. J Clin Psychiatry 1977;33:981-989.
77. Reznik I, Zemishlany Z, Kotler M, Spivak B, Weizman A, Mester R: Sildenafil citrate for the sexual dysfunction in antidepressant-treated male patients with posttraumatic stress disorder. A preliminary pilot open-label study. Psychother Psychosom 2002;71:173-176.
78. Raboch J: Sexual development and life of psychiatric female patients. Arch Sex Bahav 1986;15:341-353.
79. Raboch J, Faltus F: Sexuality of women with anorexia nervosa. Acta Psychiatr Scand 1991;84:9-11.
80. Simpson WS, Ramberg JA: Sexual dysfunction in married female patients with anorexia and bulimia nervosa. J Sex Marital Ther 1992;18:44-45.
81. Tuiten A, Panhuysen G, Everaerd W, Koppeschaar H, Drabbe P, Zelissen P: The paradoxical nature of sexuality in anorexia nervosa. J Sex Marital Ther 1993;19:259-275.
82. Morgan CD: Sexual functioning and attitudes of eating-disordered women: A follow-up study. J Sex Marital Ther 1995;21:67-77.
83. Zanarini MC, Parachini EA, Frankenburg FR, Holman JB, Hennen J, Bradford Reich D, Silk KR: Sexual relationship difficulties among borderline patients and axis II comparison subjects. J Nerv Ment Dis 2003;191:479-482.